Abstract:Hepatic encephalopathy (HE) is a debilitating neurological disorder associated with liver failure and characterized by impaired brain function. Decade-long studies have led to significant advances in our understanding of HE; however, effective therapeutic management of HE is lacking, and HE continues to be a significant cause of morbidity and mortality in patients, underscoring the need for continued research into its pathophysiology and treatment. Accordingly, the present study provides a comprehensive overview aimed at elucidating the molecular underpinnings of HE and identifying potential therapeutic targets. A moderate-grade HE model was induced in rats using thioacetamide, which simulates the liver damage observed in patients, and its impact on cognitive function, neuronal arborization, and cellular morphology was also evaluated. We employed label-free LC-MS/MS proteomics to quantitatively profile hippocampal proteins to explore the molecular mechanism of HE pathogenesis; 2175 proteins were identified, 47 of which exhibited significant alterations in moderate-grade HE. The expression of several significantly upregulated proteins, such as FAK1, CD9 and Tspan2, was further validated at the transcript and protein levels, confirming the mass spectrometry results. These proteins have not been previously reported in HE. Utilizing Metascape, a tool for gene annotation and analysis, we further studied the biological pathways integral to brain function, including gliogenesis, the role of erythrocytes in maintaining blood-brain barrier integrity, the modulation of chemical synaptic transmission, astrocyte differentiation, the regulation of organ growth, the response to cAMP, myelination, and synaptic function, which were disrupted during HE. The STRING database further elucidated the protein‒protein interaction patterns among the differentially expressed proteins. This study provides novel insights into the molecular mechanisms driving HE and paves the way for identifying novel therapeutic targets for improved disease management.

Research Progress on Hepatic Encephalopathy: Animal Models and Disease Mechanisms

Clinical and Neuroimaging Characteristics and Prognosis of Patients with Hepatic Myelopathy and Hepatic Encephalopathy

The Role of Intestinal Bacteria and Gut–Brain Axis in Hepatic Encephalopathy

Animal Models of Hepatitis E Infection: Advances and Challenges.

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

Hepatic encephalopathy: current challenges and future prospects

Advances in the diagnosis and treatment of hepatic encephalopathy

The advance of hepatic encephalopathy in basal and clinical research

2021 ISHEN guidelines on animal models of hepatic encephalopathy

Lessons on brain edema in HE: from cellular to animal models and clinical studies

Multimodality Magnetic Resonance Imaging in Hepatic Encephalopathy: an Update.

Navigating the Gut-brain Axis: Insights into the Pathogenesis of Hepatic Encephalopathy

Microbiota-gut-liver-brain axis and hepatic encephalopathy

The new concepts on hepatic encephalopathy

Pathophysiology of hepatic encephalopathy: The concept of synergism

Elucidating hippocampal proteome dynamics in moderate hepatic encephalopathy rats: insights from high-resolution mass spectrometry

Establishment of a Rat Model of Hepatic Encephalopathy

Bibliometrics and knowledge mapping of the pathogenesis of hepatic encephalopathy in patients with liver cirrhosis

Structural and Functional Magnetic Resonance Imaging in Hepatic Encephalopathy

[Research progress on albumin therapy for hepatic encephalopathy]

Research progress of BOLD-functional MRI of hepatic encephalopathy